/
/
/

Auro Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹9 Cr₹10 Cr₹9 Cr₹9 Cr₹3 Cr₹7 Cr₹3 Cr₹3 Cr₹6 Cr₹12 Cr₹18 Cr₹0₹10 Cr₹14 Cr₹16 Cr₹13 Cr₹11 Cr₹18 Cr₹12 Cr₹10 Cr₹11 Cr₹14 Cr₹13 Cr₹15 Cr₹12 Cr₹9 Cr₹10 Cr₹11 Cr₹14 Cr₹12 Cr₹12 Cr₹13 Cr₹10 Cr₹11 Cr₹12 Cr₹10 Cr₹8 Cr₹10 Cr₹7 Cr₹8 Cr₹10 Cr₹8 Cr₹9 Cr₹5 Cr₹6 Cr₹9 Cr₹8 Cr₹9 Cr₹7 Cr₹8 Cr₹8 Cr₹9 Cr₹10 Cr₹11 Cr₹11 Cr₹13 Cr
₹11 L₹66 L₹18 L₹98 L₹42 L₹13 L₹14 L₹31 L₹20 L₹40 L₹42 L₹0₹37 L₹62 L₹43 L-₹16 L₹5 L₹28 L₹2 L₹29 L₹50 L₹17 L₹25 L₹28 L₹6 L₹38 L₹11 L₹22 L₹26 L₹59 L₹7 L₹26 L₹3 L₹23 L₹12 L₹14 L₹3 L₹20 L₹10 L₹21 L₹3 L₹28 L₹60,000₹4 L₹10 L₹13 L₹3 L₹1 L₹8 L-₹6 L-₹6 L-₹15 L₹0-₹3 L₹5 L₹3 L
₹9 Cr₹10 Cr₹10 Cr₹10 Cr₹3 Cr₹8 Cr₹3 Cr₹3 Cr₹6 Cr₹12 Cr₹18 Cr₹0₹11 Cr₹14 Cr₹16 Cr₹12 Cr₹11 Cr₹18 Cr₹12 Cr₹11 Cr₹11 Cr₹14 Cr₹13 Cr₹16 Cr₹12 Cr₹10 Cr₹10 Cr₹11 Cr₹14 Cr₹12 Cr₹12 Cr₹13 Cr₹10 Cr₹12 Cr₹12 Cr₹10 Cr₹8 Cr₹10 Cr₹7 Cr₹8 Cr₹10 Cr₹8 Cr₹9 Cr₹5 Cr₹7 Cr₹9 Cr₹8 Cr₹9 Cr₹7 Cr₹8 Cr₹8 Cr₹9 Cr₹10 Cr₹11 Cr₹11 Cr₹13 Cr
₹6 Cr₹7 Cr₹6 Cr₹7 Cr₹3 Cr₹7 Cr₹3 Cr₹3 Cr₹5 Cr₹10 Cr₹14 Cr₹0₹9 Cr₹11 Cr₹15 Cr₹12 Cr₹11 Cr₹17 Cr₹11 Cr₹9 Cr₹9 Cr₹11 Cr₹11 Cr₹12 Cr₹10 Cr₹9 Cr₹8 Cr₹9 Cr₹12 Cr₹10 Cr₹10 Cr₹12 Cr₹9 Cr₹9 Cr₹11 Cr₹9 Cr₹7 Cr₹8 Cr₹7 Cr₹8 Cr₹9 Cr₹7 Cr₹8 Cr₹5 Cr₹6 Cr₹8 Cr₹8 Cr₹8 Cr₹6 Cr₹8 Cr₹8 Cr₹9 Cr₹10 Cr₹11 Cr₹10 Cr₹12 Cr
₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹45 L₹94 L₹58 L₹1 Cr₹2 Cr₹3 Cr₹5 Cr₹0₹2 Cr₹3 Cr₹88 L₹86 L₹63 L₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹96 L₹2 Cr₹89 L₹82 L₹1 Cr₹99 L₹71 L₹68 L₹74 L₹96 L₹77 L₹72 L₹63 L₹64 L₹64 L₹70 L₹69 L₹56 L₹85 L₹1 Cr
₹1 Cr₹1 Cr₹2 Cr₹96 L₹28 L₹30 L₹25 L₹28 L₹25 L-₹33 L₹45 L₹0₹27 L₹13 L₹10 L₹32 L₹26 L₹40 L₹17 L₹15 L₹11 L₹25 L₹5 L₹8 L₹8 L₹21 L₹10 L₹11 L₹16 L₹13 L₹18 L₹19 L₹23 L₹5 L₹41 L₹33 L₹30 L-₹17 L₹47 L₹40 L₹36 L₹38 L₹38 L₹41 L₹43 L₹31 L₹46 L₹42 L₹36 L₹35 L₹35 L₹39 L₹32 L₹45 L₹41 L₹43 L
₹1 Cr₹1 Cr₹2 Cr₹2 Cr-₹11 L₹35 L₹7 L₹48 L₹1 Cr₹3 Cr₹4 Cr₹0₹98 L₹3 Cr₹51 L₹29 L₹12 L₹55 L₹81 L₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹77 L₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹85 L₹2 Cr₹1 Cr₹88 L₹44 L₹2 Cr₹21 L₹22 L₹50 L₹53 L₹13 L₹7 L₹11 L₹54 L₹9 L₹9 L₹8 L₹9 L₹9 L₹12 L₹17 L-₹40,000₹24 L₹38 L
₹1 Cr₹97 L₹2 Cr₹72 L-₹11 L₹40 L₹5 L₹36 L₹75 L₹2 Cr₹3 Cr₹0₹71 L₹2 Cr₹37 L₹21 L₹8 L₹46 L₹61 L₹71 L₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹46 L₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹80 L₹64 L₹2 Cr₹1 Cr₹88 L₹44 L₹2 Cr₹21 L₹22 L₹50 L₹53 L₹13 L₹7 L₹11 L₹54 L₹9 L₹9 L₹8 L₹9 L₹9 L₹12 L₹17 L-₹40,000₹24 L₹38 L

Share Price Live Stats

Open (₹)247.95
Volume (₹)29,842.00
High (₹)267.80
Upper Circuit291.65
Low (₹)246.00
Lower Circuit194.45
Prev Close243.05
52W High (₹)317.00
Price255.05
52W Low (₹)159.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)151.48 Cr
Div. Yield (%)0.00
PE Ratio32.35
Debt to Equity1.37
Price to Book3.56
Book Value74.36
EPS (TTM)7.51
Face Value10.00
ROE (%)7.91

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
AUROLAB-XNSE
LTP
1W Low
1W High
Market cap (₹)
1904-16.1 (-0.84%)
1901
1964.85
4,63,791Cr
9245-24 (-0.26%)
9051.85
9296
2,45,081Cr
4924.7-110.3 (-2.19%)
4890
5049
1,90,351Cr
1135-52 (-4.38%)
1130.75
1191.45
1,14,833Cr
1389-29 (-2.05%)
1388.50
1426.20
1,14,163Cr
1872.15-63.15 (-3.26%)
1812
1947.90
1,00,660Cr
2135-40 (-1.84%)
2135
2209
98,431Cr
2345-42.4 (-1.78%)
2323.15
2407.40
98,305Cr
1155-22.8 (-1.94%)
1155
1179.90
96,906Cr
1627-23 (-1.39%)
1627
1706.70
95,300Cr
255.05+22.85 (9.84%)
226
267.80
151Cr

Key Highlights of Auro Laboratories Ltd’s P&L

In 2026-03-31, Auro Laboratories Ltd reported total revenue of ₹30.74Cr, compared with ₹19.12Cr in 2025-03-31, reflecting Auro Laboratories Ltd turnover.

Depreciation was ₹2.81Cr and finance costs were ₹4.25Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹4.81Cr in 2026-03-31 as compared to ₹1.88Cr in 2025-03-31.

Net Profit (PAT) was ₹3.53Cr in 2026-03-31 compared with ₹1.84Cr in 2025-03-31.

Earnings per share (EPS) were ₹5.67 in 2026-03-31, compared with ₹2.95 in 2025-03-31.